Chlamydia trachomatis genital infections. NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Chlamydia trachomatis genital infections.

W V Med J. 1993 Aug;89(8):331-4. Unique Identifier : AIDSLINE MED/93383447
Fisher MA; Section of Infectious Diseases, West Virginia University School; of Medicine, Morgantown.

Abstract: Chlamydia trachomatis genital infections are among the most common sexually transmitted diseases in the United States today. Although these organisms are obligate intracellular pathogens, they more closely resemble bacteria than viruses. C. trachomatis is responsible for considerable morbidity in women, causing urethritis, cervicitis, endometritis, and pelvic inflammatory disease. The latter complication is associated with a high incidence of infertility and ectopic pregnancy, even when the infection is asymptomatic. In young men, C. trachomatis is a common cause of urethritis and epididymitis. Diagnostic tests include tissue culture which has the greatest sensitivity and specificity but is difficult and costly, and various antigen assays which are useful in high-risk, high-prevalence populations. Treatment is effective with doxycycline or erythromycin, but success also depends on appropriate follow-up and empiric treatment of sexual partners. Control of C. trachomatis genital infections is crucial to the control of all sexually transmitted diseases including HIV infection.
Keywords: *Chlamydia trachomatis *Chlamydia Infections/DIAGNOSIS/EPIDEMIOLOGY/THERAPY Female Genital Diseases, Female/DIAGNOSIS/EPIDEMIOLOGY/THERAPY Genital Diseases, Male/DIAGNOSIS/EPIDEMIOLOGY/THERAPY Human Male JOURNAL ARTICLEKWDchlamydiatrachomatisKWDchlamydiainfections/diagnosis/epidemiology/therapyfemalegenitaldiseases,female/diagnosis/epidemiology/therapygenitaldiseases,male/diagnosis/epidemiology/therapyhumanmalejournalarticle
931230
M93C0357

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .